CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Vivalyx has developed Omnisol, a synthetic blood substitute that enhances organ preservation through warm perfusion. This technology aims to significantly increase the availability of transplantable organs by improving organ viability and function during preservation.
There are over 150,000 people on waiting lists for organ transplantation in Europe and the US today.
Current transplantations cover less than 20% of the actual need, estimated at 1M organs by the WHO, due to the shortage of available transplantable organs.
Predominantly used organ preservation methods fail at extending the pool of available organs.
Perfusion at body temperature is the optimal organ preservation technology and it can expand the donor organ pool as it enables viability assessment…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
